Elicio Therapeutics Inc. Asset Resilience Ratio

Latest as of March 2022: 22.84%

Elicio Therapeutics Inc. asset resilience ratio. Elicio Therapeutics Inc. (ELTX) has an Asset Resilience Ratio of 22.84% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ELTX days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$18.56 Million

Cash + Short-term Investments

Total Assets

$81.26 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Elicio Therapeutics Inc. (None–None)

Asset resilience ratio of Elicio Therapeutics Inc. from None to None. This chart shows how Elicio Therapeutics Inc.'s Asset Resilience Ratio has changed over time. Read ELTX liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Elicio Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Elicio Therapeutics Inc. balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$18.56 Million	22.84%
Total Liquid Assets	$18.56 Million	22.84%

Asset Resilience Insights

Good Liquidity Position: Elicio Therapeutics Inc. maintains a healthy 22.84% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Elicio Therapeutics Inc. Industry Peers by Asset Resilience Ratio

Compare Elicio Therapeutics Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
ACADIA Pharmaceuticals Inc NASDAQ:ACAD	Biotechnology	32.79%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
INVENTIVA ADS/1 O.N. F:6IVA	Biotechnology	52.73%
PYC Therapeutics Ltd AU:PYC	Biotechnology	83.51%

Elicio Therapeutics Inc. Asset Resilience Ratio by Year (None–None)

Elicio Therapeutics Inc. asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Elicio Therapeutics Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Elicio Therapeutics Inc.

NASDAQ:ELTX USA Biotechnology

Market Cap

$43.23 Million

Market Cap Rank

#22199 Global

#4925 in USA

Share Price

$1.65

Change (1 day)

+8.94%

52-Week Range

$1.40 - $14.85

All Time High

$257.40